Activation of ataxia telangiectasia muted under experimental models and human Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cellular and Molecular Life Sciences

• Publication date

  2010-05-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00018-010-0408-5PMID 20502937PMCID PMC11115894
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease.

  2009cited by this paper
• Involvment of Cytosolic and Mitochondrial GSK-3β in Mitochondrial Dysfunction and Neuronal Cell Death of MPTP/MPP+-Treated Neurons

  2009cited by this paper
• Linking Cell Cycle Reentry and DNA Damage in Neurodegeneration

  2009cited by this paper
• The p38(MAPK) signaling pathway regulates neuronal apoptosis through the phosphorylation of the retinoblastoma protein.

  2009cited by this paper
• Molecular regulation of DNA damage-induced apoptosis in neurons of cerebral cortex.

  2009cited by this paper
• Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease.

  2009cited by this paper
• Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.

  2009cited by this paper
• Overexpression of Cdk5 or Non-phosphorylatable Retinoblastoma Protein Protects Septal Neurons from Oxygen–Glucose Deprivation

  2008cited by this paper
• The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development.

  2008cited by this paper
• Delayed combinatorial treatment with flavopiridol and minocycline provides longer term protection for neuronal soma but not dendrites following global ischemia

  2008cited by this paper
• Activation of the calpain/cdk5/p25 pathway in the girus cinguli in Parkinson's disease.

  2008cited by this paper
• Tumorigenesis and neurodegeneration: two sides of the same coin?

  2008cited by this paper
• Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.

  2008cited by this paper
• What causes cell death in Parkinson's disease?

  2008cited by this paper
• Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3‐nitropropionic acid

  2008cited by this paper
• Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease.

  2008cited by this paper
• Neuroprotective effects of caffeine against complex I inhibition–induced apoptosis are mediated by inhibition of the Atm/p53/E2F‐1 path in cerebellar granule neurons

  2007influential reference
• IN PRESS NHIBITION OF CYCLIN-DEPENDENT KINASES IS NEUROPROTECTIVE N 1-METHYL-4-PHENYLPYRIDINIUM-INDUCED APOPTOSIS N NEURONS

  2007influential reference
• Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.

  2007cited by this paper
• Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases.

  2007cited by this paper
• Apoptotic action of E2F1 requires glycogen synthase kinase 3‐β activity in PC12 cells

  2007cited by this paper
• Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.

  2007cited by this paper
• The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease

  2007cited by this paper
• Glycogen synthase kinase-3beta binds to E2F1 and regulates its transcriptional activity.

  2007cited by this paper
• Inhibition of ataxia telangiectasia-p53-E2F-1 pathway in neurons as a target for the prevention of neuronal apoptosis.

  2007cited by this paper
• Alzheimer disease, the two-hit hypothesis: an update.

  2007cited by this paper
• The nature of the cell cycle in neurons: focus on a "non-canonical" pathway of DNA replication causally related to death.

  2007cited by this paper
• Cell Cycle Activation in Postmitotic Neurons is Essential for DNA Repair

  2007cited by this paper
• The dysregulation of the cell cycle and the diagnosis of Alzheimer's disease.

  2007cited by this paper
• Glycogen synthase kinase-3β binds to E2F1 and regulates its transcriptional activity

  2007cited by this paper
• Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons.

  2007cited by this paper
• Attempted cell cycle induction in post-mitotic neurons occurs in early and late apoptotic programs through Rb, E2F1, and caspase 3.

  2006cited by this paper
• Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson’s disease

  2006cited by this paper
• Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease

  2006cited by this paper
• Calpain-Regulated p35/cdk5 Plays a Central Role in Dopaminergic Neuron Death through Modulation of the Transcription Factor Myocyte Enhancer Factor 2

  2006cited by this paper
• Nuclear Ataxia-Telangiectasia Mutated (ATM) Mediates the Cellular Response to DNA Double Strand Breaks in Human Neuron-like Cells*

  2006cited by this paper
• The role of CDK5/P25 formation/inhibition in neurodegeneration.

  2006cited by this paper
• The Chk1/Cdc25A Pathway as Activators of the Cell Cycle in Neuronal Death Induced by Camptothecin

  2006cited by this paper
• Apoptosis inducing factor mediates caspase‐independent 1‐methyl‐4‐phenylpyridinium toxicity in dopaminergic cells

  2005cited by this paper
• The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease

  2005cited by this paper
• Molecular basis of programmed cell death involved in neurodegeneration.

  2005cited by this paper
• p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell death

  2005cited by this paper
• The cell cycle in Alzheimer disease: a unique target for neuropharmacology.

  2005cited by this paper
• MPP+

  2004cited by this paper
• CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease.

  2004cited by this paper
• Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death

  2004cited by this paper
• Cell cycle regulation of neuronal apoptosis in development and disease.

  2004cited by this paper
• Oxidative stress‐induced death in the nervous system: Cell cycle dependent or independent?

  2004cited by this paper
• Antiapoptotic effects of roscovitine in cerebellar granule cells deprived of serum and potassium: a cell cycle-related mechanism.

  2004cited by this paper
• Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM

  2004cited by this paper
• JNK inhibition as a potential strategy in treating Parkinson's disease.

  2004cited by this paper
• Initiation of Neuronal Damage by Complex I Deficiency and Oxidative Stress in Parkinson's Disease

  2004cited by this paper
• Cell cycle activation linked to neuronal cell death initiated by DNA damage.

  2004cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Reduced NMDA-induced apoptosis in neurons lacking ataxia telangiectasia mutated protein

  2003cited by this paper
• Oxidative stress, cell cycle, and neurodegeneration.

  2003cited by this paper
• Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease

  2003cited by this paper
• Expression Patterns of Retinoblastoma Protein in Parkinson Disease

  2003cited by this paper
• Cyclin-dependent kinases in neural development and degeneration

  2003cited by this paper
• Vitamin E blocks early events induced by 1‐methyl‐4‐phenylpyridinium (MPP+) in cerebellar granule cells

  2003cited by this paper
• Ataxia Telangiectasia-mutated Protein Can Regulate p53 and Neuronal Death Independent of Chk2 in Response to DNA Damage*

  2003cited by this paper
• Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path?

  2001cited by this paper
• Activation of oncogenic pathways in degenerating neurons in Alzheimer disease

  2000cited by this paper
• Cyclin' toward dementia

  2000cited by this paper
• Mitotic signaling by beta-amyloid causes neuronal death.

  1999cited by this paper
• Mitotic signaling by β‐amyloid causes neuronal death

  1999cited by this paper
• 1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis.

  1998cited by this paper
• Apoptosis in the absence of poly-(ADP-ribose) polymerase.

  1997cited by this paper
• Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

  1997cited by this paper

• Histone Post-Translational Modifications and DNA Double-Strand Break Repair in Neurodegenerative Diseases: An Epigenetic Perspective

  2025cites this paper
• DNA Damage Response Regulation Alleviates Neuroinflammation in a Mouse Model of α-Synucleinopathy

  2025cites this paper
• Crosstalk between DNA damage and cGAS-STING immune pathway drives neuroinflammation and dopaminergic neurodegeneration in Parkinson's disease.

  2025cites this paper
• A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies

  2025cites this paper
• Novel Techniques for Mapping DNA Damage and Repair in the Brain

  2024cites this paper
• Targeting the Cysteine Redox Proteome in Parkinson’s Disease: The Role of Glutathione Precursors and Beyond

  2023cites this paper
• Upregulated DNA Damage-Linked Biomarkers in Parkinson's Disease Model Mice

  2023cites this paper
• DNA Damage-Mediated Neurotoxicity in Parkinson’s Disease

  2023cites this paper
• Decoding the Role of Familial Parkinson’s Disease-Related Genes in DNA Damage and Repair

  2022influential citation
• Regulatory mechanism of cyclins and cyclin-dependent kinases in post-mitotic neuronal cell division.

  2021cites this paper
• Brain Selective Estrogen Treatment Protects Dopaminergic Neurons and Preserves Behavioral Function in MPTP-induced Mouse Model of Parkinson’s Disease

  2020cites this paper
• DNA damage and repair in Parkinson's disease: Recent advances and new opportunities

  2020cites this paper
• DNA double-strand breaks: a potential therapeutic target for neurodegenerative diseases

  2019cites this paper
• α‐Synuclein toxicity in yeast and human cells is caused by cell cycle re‐entry and autophagy degradation of ribonucleotide reductase 1

  2019cites this paper
• Poly-glycine–alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3

  2019cites this paper
• 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines

  2017cites this paper
• The ATM kinase inhibitor KU-55933 provides neuroprotection against hydrogen peroxide-induced cell damage via a γH2AX/p-p53/caspase-3-independent mechanism: Inhibition of calpain and cathepsin D.

  2017cites this paper
• Re-expression of cell cycle markers in aged neurons and muscles: Whether cells should divide or die?

  2017cites this paper
• NEUROPROTECTIVE ROLE OF BIMOCLOMOL IN ECTOPIC CELL CYCLE IN PARKINSON’S DISEASE: NEW INSIGHTS

  2017cites this paper
• Molecular changes in the postmortem parkinsonian brain

  2016cites this paper
• Role of the Cell Cycle Re-Initiation in DNA Damage Response of Post-Mitotic Cells and Its Implication in the Pathogenesis of Neurodegenerative Diseases

  2016cites this paper
• Health risks for ataxia‐telangiectasia mutated heterozygotes: a systematic review, meta‐analysis and evidence‐based guideline

  2016cites this paper
• DNA Double Strand Breaks: A Common Theme in Neurodegenerative Diseases.

  2016cites this paper
• The associations between Parkinson’s disease and cancer: the plot thickens

  2015cites this paper
• Oxidative stress, redox homeostasis and NF-κB signaling in neurodegeneration

  2015cites this paper
• Immunohistochemical localization of spatacsin in α‐synucleinopathies

  2014cites this paper
• Induction of Dickkopf-1 contributes to the neurotoxicity of MPP+ in PC12 cells via inhibition of the canonical Wnt signaling pathway.

  2013cites this paper
• Role of Cell Cycle Re-Entry in Neurons: A Common Apoptotic Mechanism of Neuronal Cell Death

  2012cites this paper
• Parkinson disease: identifying different players sharing a common principle

  2011cites this paper